Sionna Therapeutics Common Stock Market Value
| SION Stock | 38.02 1.20 3.26% |
| Symbol | Sionna |
Will Biotechnology sector continue expanding? Could Sionna diversify its offerings? Factors like these will boost the valuation of Sionna Therapeutics. If investors know Sionna will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sionna Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Sionna Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Sionna Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Sionna Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Sionna Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sionna Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Sionna Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.
Sionna Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sionna Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sionna Therapeutics.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Sionna Therapeutics on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Sionna Therapeutics Common or generate 0.0% return on investment in Sionna Therapeutics over 90 days. Sionna Therapeutics is related to or competes with Janux Therapeutics, Abcellera Biologics, Maze Therapeutics, Biohaven Pharmaceutical, Celldex Therapeutics, Vera Therapeutics, and Xeris Pharmaceuticals. Sionna Therapeutics is entity of United States More
Sionna Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sionna Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sionna Therapeutics Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.77 | |||
| Information Ratio | 0.0157 | |||
| Maximum Drawdown | 31.39 | |||
| Value At Risk | (8.89) | |||
| Potential Upside | 7.92 |
Sionna Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sionna Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sionna Therapeutics' standard deviation. In reality, there are many statistical measures that can use Sionna Therapeutics historical prices to predict the future Sionna Therapeutics' volatility.| Risk Adjusted Performance | 0.0365 | |||
| Jensen Alpha | 0.1453 | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | 0.0138 | |||
| Treynor Ratio | 0.6559 |
Sionna Therapeutics February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0365 | |||
| Market Risk Adjusted Performance | 0.6659 | |||
| Mean Deviation | 3.27 | |||
| Semi Deviation | 5.44 | |||
| Downside Deviation | 5.77 | |||
| Coefficient Of Variation | 2854.59 | |||
| Standard Deviation | 5.08 | |||
| Variance | 25.79 | |||
| Information Ratio | 0.0157 | |||
| Jensen Alpha | 0.1453 | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | 0.0138 | |||
| Treynor Ratio | 0.6559 | |||
| Maximum Drawdown | 31.39 | |||
| Value At Risk | (8.89) | |||
| Potential Upside | 7.92 | |||
| Downside Variance | 33.25 | |||
| Semi Variance | 29.63 | |||
| Expected Short fall | (3.01) | |||
| Skewness | (0.22) | |||
| Kurtosis | 3.09 |
Sionna Therapeutics Backtested Returns
As of now, Sionna Stock is not too volatile. Sionna Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0284, which indicates the firm had a 0.0284 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Sionna Therapeutics Common, which you can use to evaluate the volatility of the company. Please validate Sionna Therapeutics' Semi Deviation of 5.44, risk adjusted performance of 0.0365, and Coefficient Of Variation of 2854.59 to confirm if the risk estimate we provide is consistent with the expected return of 0.15%. Sionna Therapeutics has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 0.26, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sionna Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Sionna Therapeutics is expected to be smaller as well. Sionna Therapeutics right now has a risk of 5.3%. Please validate Sionna Therapeutics value at risk, as well as the relationship between the skewness and day median price , to decide if Sionna Therapeutics will be following its existing price patterns.
Auto-correlation | -0.26 |
Weak reverse predictability
Sionna Therapeutics Common has weak reverse predictability. Overlapping area represents the amount of predictability between Sionna Therapeutics time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sionna Therapeutics price movement. The serial correlation of -0.26 indicates that nearly 26.0% of current Sionna Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.26 | |
| Spearman Rank Test | -0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 6.6 |
Pair Trading with Sionna Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sionna Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sionna Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Sionna Stock
| 0.56 | KRRO | Frequency Therapeutics | PairCorr |
| 0.55 | EVGN | Evogene | PairCorr |
| 0.51 | JUMP | Leveljump Healthcare Corp | PairCorr |
| 0.37 | QSI | QuantumSi | PairCorr |
The ability to find closely correlated positions to Sionna Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sionna Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sionna Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sionna Therapeutics Common to buy it.
The correlation of Sionna Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sionna Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sionna Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sionna Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Sionna Therapeutics Correlation, Sionna Therapeutics Volatility and Sionna Therapeutics Performance module to complement your research on Sionna Therapeutics. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Sionna Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.